Screening Colonoscopy to Reduce the Incidence and Mortality of Colorectal Cancer.

IF 3 3区医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Digestion Pub Date : 2024-10-22 DOI:10.1159/000542113

Naoya Tada, Naoto Tamai, Kazuki Sumiyama

{"title":"Screening Colonoscopy to Reduce the Incidence and Mortality of Colorectal Cancer.","authors":"Naoya Tada, Naoto Tamai, Kazuki Sumiyama","doi":"10.1159/000542113","DOIUrl":null,"url":null,"abstract":"Background: Colorectal cancer (CRC) is a major concern because of its increasing incidence and mortality worldwide. Therefore, effective screening strategies are necessary to reduce its incidence.Summary: In addition to fecal immunochemical tests and computed tomography colonography, screening colonoscopy is expected to significantly contribute to the reduction of CRC. However, the timing of colonoscopy for CRC screening is not well-defined because of the lack of sufficient data. Additionally, the effectiveness of colonoscopy is affected by various factors known as quality indicators (QIs), such as the performance of the endoscopist; therefore, there are concerns regarding quality assurance. The adenoma detection rate (ADR) is a well-known QI of colonoscopy. Substantial evidence has suggested that improving the ADR could reduce the incidence and mortality of postcolonoscopy CRC.Key messages: Recent technological advancements have led to the development of image-enhanced endoscopy and the incorporation of artificial intelligence, and their ability to improve the ADR has been assessed. This review focused on screening colonoscopies and QIs and their ability to improve the ADR and incidence and mortality of CRC.","PeriodicalId":11315,"journal":{"name":"Digestion","volume":" ","pages":"1-7"},"PeriodicalIF":3.0000,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Digestion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000542113","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Colorectal cancer (CRC) is a major concern because of its increasing incidence and mortality worldwide. Therefore, effective screening strategies are necessary to reduce its incidence.

Summary: In addition to fecal immunochemical tests and computed tomography colonography, screening colonoscopy is expected to significantly contribute to the reduction of CRC. However, the timing of colonoscopy for CRC screening is not well-defined because of the lack of sufficient data. Additionally, the effectiveness of colonoscopy is affected by various factors known as quality indicators (QIs), such as the performance of the endoscopist; therefore, there are concerns regarding quality assurance. The adenoma detection rate (ADR) is a well-known QI of colonoscopy. Substantial evidence has suggested that improving the ADR could reduce the incidence and mortality of postcolonoscopy CRC.

Key messages: Recent technological advancements have led to the development of image-enhanced endoscopy and the incorporation of artificial intelligence, and their ability to improve the ADR has been assessed. This review focused on screening colonoscopies and QIs and their ability to improve the ADR and incidence and mortality of CRC.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

通过筛查结肠镜降低结肠直肠癌的发病率和死亡率。

背景：结肠直肠癌（CRC）的发病率和死亡率在全球范围内不断上升，成为人们关注的焦点。摘要：除了粪便免疫化学检验和计算机断层扫描结肠造影术外，结肠镜筛查预计也将大大有助于减少 CRC 的发病率。然而，由于缺乏足够的数据，结肠镜检查用于 CRC 筛查的时机尚未明确。此外，结肠镜检查的效果还受到被称为质量指标（QIs）的各种因素的影响，例如内镜医师的表现；因此，质量保证问题备受关注。腺瘤检出率（ADR）是众所周知的结肠镜检查质量指标。大量证据表明，提高腺瘤检出率可以降低结肠镜检查后 CRC 的发病率和死亡率：近期的技术进步促进了图像增强内镜和人工智能的发展，并对其提高 ADR 的能力进行了评估。本综述的重点是筛查结肠镜和 QIs 及其改善 ADR 以及 CRC 发病率和死亡率的能力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Digestion 医学-胃肠肝病学

CiteScore

7.90

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： ''Digestion'' concentrates on clinical research reports: in addition to editorials and reviews, the journal features sections on Stomach/Esophagus, Bowel, Neuro-Gastroenterology, Liver/Bile, Pancreas, Metabolism/Nutrition and Gastrointestinal Oncology. Papers cover physiology in humans, metabolic studies and clinical work on the etiology, diagnosis, and therapy of human diseases. It is thus especially cut out for gastroenterologists employed in hospitals and outpatient units. Moreover, the journal''s coverage of studies on the metabolism and effects of therapeutic drugs carries considerable value for clinicians and investigators beyond the immediate field of gastroenterology.